CONSOLIDATED STATEMENTS OF INCOME (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Product revenue	$ 1,445.6	$ 1,145.4	$ 985.3
Service revenue	194.8	151.1	122.4
Other revenue	11.3	8.4	6.8
Total revenue	1,651.7	1,304.9	1,114.5
Cost of product revenue	792.5	621.5	526.3
Cost of service revenue	106.7	79.4	70.7
Total cost of revenue	899.2	700.9	597.0
Gross profit	752.5	604.0	517.5
Operating expenses:
Selling, general and administrative	406.6	301.1	254.0
Research and development	177.2	141.4	126.4
Write-off of deferred offering costs	3.4
Other charges, net	9.7	5.8	0.4
Total operating expenses	596.9	448.3	380.8
Operating income	155.6	155.7	136.7
Interest and other income (expense), net	(10.1)	(5.6)	(7.6)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	145.5	150.1	129.1
Income tax provision	51.5	53.3	48.1
Consolidated net income	94.0	96.8	81.0
Net income (loss) attributable to noncontrolling interest in consolidated subsidiaries	1.7	1.4	(0.2)
Net income attributable to Bruker Corporation	$ 92.3	$ 95.4	$ 81.2
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.56	$ 0.58	$ 0.50
Diluted (in dollars per share)	$ 0.55	$ 0.58	$ 0.49
Weighted average common shares outstanding:
Basic (in shares)	165.4	164.4	163.5
Diluted (in shares)	166.9	165.7	164.9